$NAUT News

Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans

Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...

Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript

Nautilus Biotechnology Q1 Earnings Call Highlights

Nautilus Biotechnology Reports First Quarter 2026 Financial Results

Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript

Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year

Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Guggenheim Maintains Buy on Nautilus Biotechnology, Raises Price Target to $4

Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary

Nautilus Biotechnology Q4 Earnings Call Highlights

Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ...

Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway

Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results